Skip to main content

Table 4 Frequency of specific immune-related adverse events

From: Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events

Immune-related adverse event G1/2, n (%) G3/4, n (%)
Skin (rash) 3 (13.0%) 0
Arthritis 3 (13.0%) 0
Colitis 0 2 (8.7%)
Encephalitis 0 2 (8.7%)
Hypothyroidism 1 (4.3%) 0
Pneumonitis 0 1 (4.3%)
Neuropathy 0 1 (4.3%)